Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)

NSE:BIOFILCHEM Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	7.09	5.6	6.98	12.41	12.07
Depreciation & Amortization	3.99	4.29	4.28	4.12	4.08
Other Operating Activities	2.34	-0.54	0.51	0.73	1.49
Change in Accounts Receivable	-125.26	-133.29	100.44	124.91	-176.84
Change in Inventory	-13.36	0.8	30.51	-26.52	-5.01
Change in Accounts Payable	149.05	120.54	-152.56	-100.66	173.34
Change in Other Net Operating Assets	0.09	1.48	7.64	-3.88	-0.19
Operating Cash Flow	23.94	-1.12	-2.2	11.11	8.94
Operating Cash Flow Growth	-	-	-	24.23%	-90.60%
Capital Expenditures	-0.23	-0.11	-0.7	-5.67	-2.07
Sale of Property, Plant & Equipment	-	-	-	4.71	-
Investing Cash Flow	-0.23	-0.11	-0.7	-0.96	-2.07
Long-Term Debt Issued	-	0.58	0.35	-	-
Total Debt Issued	-	0.58	0.35	-	-
Short-Term Debt Repaid	-	-	-	-7.62	-4.45
Long-Term Debt Repaid	-0.83	-	-	-	-
Total Debt Repaid	-0.83	-	-	-7.62	-4.45
Net Debt Issued (Repaid)	-0.83	0.58	0.35	-7.62	-4.45
Other Financing Activities	-0.42	-0.43	-0.41	-0.68	-1.22
Financing Cash Flow	-1.25	0.15	-0.06	-8.3	-5.68
Miscellaneous Cash Flow Adjustments	-	-	-	-	-0
Net Cash Flow	22.46	-1.07	-2.96	1.85	1.2
Free Cash Flow	23.71	-1.22	-2.9	5.44	6.88
Free Cash Flow Growth	-	-	-	-20.84%	-91.51%
Free Cash Flow Margin	5.87%	-0.41%	-1.29%	1.52%	2.31%
Free Cash Flow Per Share	1.46	-0.07	-0.18	0.33	0.42
Cash Interest Paid	0.4	0.42	0.39	0.64	1.22
Cash Income Tax Paid	2.4	2.3	2.71	3.28	2.49
Levered Free Cash Flow	19.89	-0.62	-4.6	0.61	2.34
Unlevered Free Cash Flow	20.14	-0.36	-4.36	1.01	3.1
Change in Net Working Capital	-10.75	9.75	14.4	9.71	8.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.